Organisation: State Administration for Market Regulation (China)

Intel/Tower abandon merger amid delayed review in China

Intel has axed its €5.5 billion purchase of Tower Semiconductor after failing to secure antitrust approval in China, making it the latest US chipmaker to be snared by growing trade tensions.

16 August 2023

Another Intel/Tower deadline passes without Chinese approval

Intel and Tower Semiconductor must decide whether to abandon their €5.5 billion tie-up or agree to a third merger deadline extension after failing to secure approval from China’s competition watchdog.

15 August 2023

Chinese pig breeders scrap no-poach agreement after SAMR sounds alarm

The four largest pig breeders in China have withdrawn a pledge not to poach each other’s employees after the country’s antitrust watchdog voiced concerns.

02 August 2023

China sanctions school insurance cartel

China’s State Administration for Market Regulation has penalised eight companies a total of €1.5 million for dividing the market and fixing the premium prices of personal accident insurance covering primary and secondary school students.

20 June 2023

SAMR punishes drug wholesalers for price-fixing cancer treatment injections

China’s antitrust watchdog has fined two drug wholesalers €7.5 million for price-fixing and dividing the market for a cancer treatment injection, continuing its aggressive enforcement in the pharmaceutical sector.

05 June 2023

China sanctions gas utility for illegal tying and charging excessive prices

A Chinese domestic gas utility must pay roughly €6.6 million for abusing its dominance in the natural gas pipeline supply service market, after unlawfully tying its pipeline projects with its other services and charging unjustly high installation fees.

05 June 2023

China sanctions pharmaceutical company for RPM over contraceptives

China’s State Administration for Market Regulation has fined a pharmaceutical company €1.7 million for fixing the resale price of two widely-used emergency contraceptives for six years.

01 June 2023

China issues first joint cartel and abuse fine to epinephrine maker

China’s competition authority has for the first time ever sanctioned a company for cartel conduct and abuse of dominance in a single case – slapping an active pharmaceutical ingredient supplier with a €37.7 million penalty.

31 May 2023

SAMR approves domestic chemical deal with FRAND commitments

China’s antitrust authority has approved Wanhua Chemical Group’s acquisition of a domestic rival subject to extensive behavioural remedies, which include pricing commitments and supplying domestic customers on fair, reasonable and non-discriminatory terms.

12 April 2023

SAMR delaying merger reviews involving US tech companies

China’s antitrust authority has reportedly slowed down its reviews of several transactions involving acquisitions by US technology companies as the trade relationship between the world’s two largest economies remains strained.

06 April 2023

Unlock unlimited access to all Global Competition Review content